The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain

British Journal of Pharmacology

Volumn 133, Issue 4, 2001, Pages 586-594

  Bridges, Daniel ^a,b   Ahmad, Kamran ^a   Rice, Andrew S C ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b Novartis Inst for Medical Sciences   (United Kingdom)

Author keywords

Allodynia; Analgesia; Cannabinoid; Hyperalgesia; Neuropathic pain; SR141716a; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NERVE LIGATION; NEUROPATHY; NONHUMAN; PAIN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RAT; SPINAL NERVE; THERMAL STIMULATION;

EID: 0034951162     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704110     Document Type: Article

References (48)

1. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons
2. Von Frey hairs compared with a force transducer for sensory measurement in normal and neuropathic rats
3. Endocannabinoids control spasticity in a multiple sclerosis model
4. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
5. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
6. Regulation of opioid binding sites in the superficial dorsal horn of the rat spinal cord following loose ligation of the sciatic nerve: Comparison with sciatic nerve section and lumbar dorsal rhizotomy
7. 2 receptor
8. Control of pain initiation by endogenous cannabinoids
9. Behavioural manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primate
10. Determination and characterisation of a cannabinoid receptor in rat brain
11. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
12. 1 receptor expression in rat spinal cord
13. The role of central and peripheral CB1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
14. Isolation, structure, and partial synthesis of an active constituent of hashish
15. 2 receptor absence in the rat central nervous system
16. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
17. The analgesic effects of R(+)-Win 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
18. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord
19. Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment
20. i in the inhibition of adenylate cyclase by cannabimimetic drugs
21. 2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
22. 2 ligand palmitoylethanolamide, prevents the viscero-visceral hyperreflexia associated with inflammation of the rat urinary bladder
23. Effects of cannabinoids on neurons in the superficial medullary dorsal horn of the rat
24. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
25. Comparison of three rodent neuropathic pain models
26. 1 receptor
27. 1 receptor knockout mice
28. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
29. Two distinctive antinociceptive systems in rats with pathological pain
30. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
31. A systematic review of antidepressants in neuropathic pain
32. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
33. Assessing mechanical allodynia in the rat paw with a new electronic algometer
34. Molecular characterisation of a peripheral receptor for cannabinoids
35. 1 receptor activity
36. The psychologic and physiologic effects of active cannabinoids
37. 1 receptors
38. Biochemical and pharmacological characterisation of SR141716a, the first potent and selective brain cannabinoid receptor antagonist
39. 2 cannabinoid receptor
40. The debate over opioids and neuropathic pain
41. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury
42. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
43. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity
44. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
45. 1 receptors in the rat central nervous system
46. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment and endoneurial TNF-α expression
47. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716a